文献速递遗传性与小管间质肾病

血小板反应蛋白的免疫调节与肾脏

Thrombospondin immune regulation and the kidney.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

本文综述血小板反应蛋白(TSP)在肾脏中的作用,TSP1 是肾细胞中转化生长因子-β(TGF-β)的主要激活因子并发挥促炎作用,TSP2 无 TGF-β 激活能力但调控基质重塑与炎症;TSP1 抑制剂在输尿管梗阻小鼠模型中可预防间质纤维化进展,但需进一步研究评估人体安全性。

要点

  • TSP1 是肾细胞中 TGF-β 的主要激活因子,在体外和体内均发挥促炎作用。
  • TSP2 缺乏激活 TGF-β 的能力,但在实验性肾病中调控基质重塑与炎症。
  • TSP1 抑制剂在输尿管梗阻小鼠模型中预防了进行性间质纤维化。

核心结论

  • 抑制 TSP1 以控制潜在 TGF-β 激活可能是预防肾间质纤维化的新潜在靶点,但需进一步研究评估 TSP1 介导的 TGF-β 激活能否安全用于人类。

研究设计与样本

  • 本文为综述,总结 TSP 在肾脏免疫调节中的作用,相关效应多基于单侧输尿管梗阻小鼠模型的研究。

主要发现

  • 在健康肾脏中表达 TSP1 和 TSP2,二者作用相反。
  • 在单侧输尿管梗阻小鼠模型中,TSP1 表达随间质纤维化和 TGF-β 发展而增加。
  • 解除梗阻后肾功能逐渐改善,TSP1 和 TGF-β1 表达下降。
  • TSP1 抑制剂在输尿管梗阻小鼠模型中预防了进行性间质纤维化。
  • TSP 在体内通常发挥抑制肿瘤的作用,TGF-β 可诱导调节性 T 细胞产生并抑制 B 细胞反应。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • TSP 在肾脏中的作用多基于单侧输尿管梗阻小鼠模型研究。
  • 需进一步研究评估 TSP1 介导的 TGF-β 激活能否安全用于人类。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Most therapeutic attempts to prevent the progression of kidney diseases have been based on interventions to inhibit the production of transforming growth factor-β (TGF-β). Thrombospondins (TSPs) play an important role in activating TGF-β. In the healthy kidney, two TSPs are expressed, TSP1 and TSP2, which exert contrasting effects. While TSP1 is a major activator of TGF-β in renal cells and exerts pro-inflammatory effects both in vitro and in vivo, TSP2 lacks the ability for TGF-β activation but regulates matrix remodeling and inflammation in experimental kidney disease. The effects of TSPs in the kidney have been mostly investigated by using the murine model of unilateral ureteral obstruction. In this model, TSP1 expression is increased along with the development of interstitial fibrosis and TGF-β. Relief of the obstruction gradually improves renal function and decreases the expression in TSP1 and TGF-β1. Several inhibitors of TSP1 prevented progressive interstitial fibrosis in murine models of ureteral obstruction, suggesting that control of latent TGF-β activation by inhibiting TSP1 might represent a novel potential target for preventing renal interstitial fibrosis. However, further studies are needed to assess whether TSP1-mediated TGF-β activation can be safely used in humans. In fact, TSPs normally act to suppress tumors in vivo. Moreover, TGF-β can exert a pivotal function in the immune system, as it may induce the production of regulatory T cells and suppress B cell responses. Knowledge of the molecular mechanisms involved in TGF-β regulation may help in finding effective treatments of tissue fibrosis, cancer and autoimmune disease.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Ponticelli C, Anders HJ. Thrombospondin immune regulation and the kidney. Nephrol Dial Transplant. 2017. PMID: 28088772. doi:10.1093/ndt/gfw431

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。